Audited Results of Bal Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	302.50	338.54	303.10	280.37	249.31
Manufacturing Expenses	8.29	7.57	6.71	5.37	4.70
Personnel Expenses	61.83	56.11	51.91	44.46	39.62
Selling Expenses	4.65	3.21	2.90	2.22	1.41
Administrative Expenses	39.50	47.15	45.16	38.35	26.43
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	272.42	306.10	277.07	257.16	222.99
Operating Profit	30.08	32.44	26.03	23.20	26.32
Other Recurring Income	2.15	3.35	2.15	6.49	2.69
Adjusted PBDIT	32.23	35.79	28.19	29.69	29.01
Financial Expenses	16.85	15.24	12.16	10.40	11.96
Depreciation	9.65	8.45	7.48	7.24	7.26
Other Write offs	0	0	0	0	0
Adjusted PBT	5.73	12.11	8.55	12.06	9.80
Tax Charges	-2.07	1.83	2.42	3.48	0.70
Adjusted PAT	7.80	10.27	6.13	8.58	9.10
Non Recurring Items	-0.05	0	0	0	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	7.80	10.27	6.13	8.58	9.10
Equity Dividend	1.91	1.57	1.56	1.48	0
Preference Dividend	0	0	0	0	0
Retained Earnings	48.74	55.64	46.94	42.37	35.27

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article